
Latest Science News
Three Immunologists Awarded Nobel Prize for Regulatory T Cell Discoveries
Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi received the Nobel Prize in Physiology or Medicine for discoveries on regulatory T cells preventing immune attacks on the body. Their work underpins modern immunology and T cell cancer therapies. A lecture on their findings is available on YouTube.
Link Industries Launches with $60M for Next-Gen CAR-T Therapies
Biotech firm Link Industries launched on December 15, 2025, with $60 million Series A funding led by Johnson & Johnson to develop advanced CAR-T cancer treatments. The company aims to innovate T cell therapies for broader cancer applications.
Rockefeller Researchers Unveil Key T-Cell Receptor Function Insights
Findings from The Rockefeller University reveal how T-cell receptors (TCR) activate upon antigen encounter in a replicated in vivo environment, challenging prior electron microscopy results. This deepens understanding for refining T cell therapies against new cancers.
Illumina Launches Billion Cell Atlas for AI Drug Discovery
Illumina introduced the Billion Cell Atlas, the largest genome-wide genetic perturbation dataset using CRISPR on over 200 disease-relevant cell lines for cancer, immune disorders, and more. It enables AI model training for precision medicine and target validation.